(Q48709458)

14 February 2018

title

Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis (English)

1 reference

14 February 2018

1 reference

1

1 reference

14 February 2018

author name string

Browning JL

2

1 reference

14 February 2018

Lawton P

3

1 reference

14 February 2018

Shah SA

4

1 reference

14 February 2018

Comiskey M

5

1 reference

14 February 2018

Bhan AK

6

1 reference

14 February 2018

Mizoguchi E

7

1 reference

14 February 2018

Terhorst C

8

1 reference

14 February 2018

Simpson SJ

9

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 December 1998

1 reference

14 February 2018

published in

Gastroenterology

1 reference

14 February 2018

volume

115

1 reference

14 February 2018

issue

6

1 reference

14 February 2018

page(s)

1464-1475

1 reference

14 February 2018

Inflammatory bowel disease (1)

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Cytokines in intestinal inflammation: pathophysiological and clinical considerations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Experimental models of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Expression of pro-inflammatory cytokines by TCR alpha beta+ and TCR gamma delta+ T cells in an experimental model of colitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

T cells in inflammatory bowel disease: protective and pathogenic roles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Cytokine regulation of experimental intestinal inflammation in genetically engineered and T-lymphocyte reconstituted rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Antibodies to interleukin 12 abrogate established experimental colitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune re

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Characterization of tumor necrosis factor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Biological therapies: a novel approach to the treatment of autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Role of cytokines in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Two tumour necrosis factor receptors: structure and function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Lymphotoxin-alpha-deficient and TNF receptor-I-deficient mice define developmental and functional characteristics of germinal centers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Crucial role of tumor necrosis factor receptor 1 expression on nonhematopoietic cells for B cell localization within the splenic white pulp

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

The sequential role of lymphotoxin and B cells in the development of splenic follicles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Distinct roles of lymphotoxin alpha and the type I tumor necrosis factor (TNF) receptor in the establishment of follicular dendritic cells from non-bone marrow-derived cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Turning off follicular dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Developmental control point in induction of thymic cortex regulated by a subpopulation of prothymocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Severe colitis in mice with aberrant thymic selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Over-expression of CD3 epsilon transgenes blocks T lymphocyte development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

DNA flow cytometric evaluation of cell cycle distribution in ulcerative colitis: a proposed method for assessing severity of disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Frequency and histological appearance of adenomas in multiple intestinal neoplasia mice are unaffected by severe combined immunodeficiency (scid) mutation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Independent signals regulate development of primary and secondary follicle structure in spleen and mesenteric lymph node

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Murine psoriasis-like disorder induced by naive CD4+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Affinity maturation without germinal centres in lymphotoxin-alpha-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Chronic inflammation caused by lymphotoxin is lymphoid neogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

The expanding universe of T-cell subsets: Th1, Th2 and more.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970025-3

10.1016/S0016-5085(98)70025-3

7 January 2021

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018